This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, G. M.
Right arrow Articles by Nettleman, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, G. M.
Right arrow Articles by Nettleman, M. D.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Influenza

PEDIATRICS Vol. 106 No. 5 November 2000, pp. 973-976

Economic Impact of Influenza Vaccination in Preschool Children

Received Dec 17, 1999; accepted Mar 31, 2000.

Gail M. Cohen* and Mary D. Nettleman*

From the * Virginia Commonwealth University School of Medicine, Richmond, Virginia.

Objective.  The economic impact of routine vaccination of preschool children with inactivated influenza vaccine was investigated.

Design.  A decision analysis was performed using data from the literature. Direct and indirect costs of each vaccination strategy were calculated and compared with a strategy of not vaccinating.

Setting.  Two settings were evaluated: a setting in which vaccination was available during flexible hours and a setting in which vaccination was available only during usual work hours (8:00 am-5:00 pm).

Results.  Vaccination resulted in a net cost savings in both settings. The net savings per vaccine recipient were $21.28 in the flexible setting and $1.20 in the restricted setting. Although the analysis was performed for the inactivated vaccine, sensitivity analysis showed that the nasal vaccine could also result in a net cost savings depending on the price of the cold-adapted vaccine when it is licensed.

Conclusion.  Vaccinating preschool children is economically advantageous. Serious consideration should be given to recommending vaccination in this age group.  Key words:  influenza, cost-effectiveness, vaccination, children, cost.




This article has been cited by other articles:


Home page
 PediatricsHome page
Committee on Infectious Diseases
Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2007-2008
Pediatrics, April 1, 2008; 121(4): e1016 - e1031.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. I. Shah, M. Caprio, and K. Hendricks-Munoz
Administration of Inactivated Trivalent Influenza Vaccine to Parents of High-Risk Infants in the Neonatal Intensive Care Unit
Pediatrics, September 1, 2007; 120(3): e617 - e621.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. Keren, T. E. Zaoutis, S. Saddlemire, X. Q. Luan, and S. E. Coffin
Direct Medical Cost of Influenza-Related Hospitalizations in Children
Pediatrics, November 1, 2006; 118(5): e1321 - e1327.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
N Principi, S Esposito, R Gasparini, P Marchisio, P Crovari, and for the Flu-Flu Study Group*
Burden of influenza in healthy children and their households
Arch. Dis. Child., November 1, 2004; 89(11): 1002 - 1007.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
Committee on Infectious Diseases
Recommendations for Influenza Immunization of Children
Pediatrics, May 1, 2004; 113(5): 1441 - 1447.
[Abstract] [Full Text] [PDF]

Home page
 American Journal of Medical QualityHome page
D. Fetterolf and R. West
The Business Case for Quality: Combining Medical Literature Research with Health Plan Data to Establish Value for Nonclinical Managers
American Journal of Medical Quality, March 1, 2004; 19(2): 48 - 55.
[Abstract] [PDF]

Home page
 PediatricsHome page
M. A. O'Brien, T. M. Uyeki, D. K. Shay, W. W. Thompson, K. Kleinman, A. McAdam, X.-J. Yu, R. Platt, and T. A. Lieu
Incidence of Outpatient Visits and Hospitalizations Related to Influenza in Infants and Young Children
Pediatrics, March 1, 2004; 113(3): 585 - 593.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
M. J. Gaglani and G. B. Herschler
Every Nose Counts: A New Influenza Vaccine for All Healthy Schoolchildren?
Clinical Pediatrics, January 1, 2004; 43(1): 35 - 41.
[Abstract] [PDF]

Home page
 NEJMHome page
S. S. Chiu, Y. L. Lau, K. H. Chan, W. H. S. Wong, and J.S. M. Peiris
Influenza-Related Hospitalizations among Children in Hong Kong
N. Engl. J. Med., December 26, 2002; 347(26): 2097 - 2103.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. B. Rennels, H. C. Meissner, and Committee on Infectious Diseases
Technical Report: Reduction of the Influenza Burden in Children
Pediatrics, December 1, 2002; 110(6): e80 - e80.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
Committee on Infectious Diseases
Reduction of the Influenza Burden in Children
Pediatrics, December 1, 2002; 110(6): 1246 - 1252.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
K. M. Edwards and K. A. Poehling
Influenza Virus Continues to Pose New Challenges
Pediatrics, October 1, 2001; 108(4): 1004 - 1005.
[Full Text] [PDF]

Home page
 PediatricsHome page
B. R. Luce, K. M. Zangwill, C. S. Palmer, P. M. Mendelman, L. Yan, M. C. Wolff, I. Cho, S. M. Marcy, D. Iacuzio, and R. B. Belshe
Cost-Effectiveness Analysis of an Intranasal Influenza Vaccine for the Prevention of Influenza in Healthy Children
Pediatrics, August 1, 2001; 108 (2): e24 - e24.
[Abstract] [Full Text] [PDF]